Hyo Sup Shim

机构：Yonsei University, Severance Hospital, Yonsei University Health System · ORCID：0000-0002-5718-3624

发表论文 266 篇 · 总被引 7494 次 · h-index 45

代表论文

• Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee (2024 · Journal of Thoracic Oncology · 被引 41)
• Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA) (2024 · Journal of Thoracic Oncology · 被引 25)
• The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis (2023 · Experimental & Molecular Medicine · 被引 19)
• ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer (2023 · Cancer Research and Treatment · 被引 16)
• Computed Tomography Radiomics for Preoperative Prediction of Spread Through Air Spaces in the Early Stage of Surgically Resected Lung Adenocarcinomas (2024 · Yonsei Medical Journal · 被引 14)
• Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer (2025 · 癌症：英文版 · 被引 10)